The underlying causes of most cancers are mutations that either activate proto-oncogenes, genes that lead to uncontrolled cell growth and division, and/or inactivate tumor suppressor genes, genes that protect against uncontrolled cell growth and division. These mutations can come from a number of different sources: they can be inherited from one's parents, they can come about due to exposure to mutagens and carcinogens in the environment, or they can arise during the normal course of cell division (see the
Insight article that Choppy linked to).
Of course, cancer is not one single disease but rather a
collection of related diseases. Cancers from different parts of the body are often very different from each other both in how the disease manifests itself and in the specific mutations that drive the disease. Sometimes, cancers of the same body type can be very different between individuals (cancer cells within the same individual can also be quite different from each other). For example, there are many different subtypes of breast cancer, some of which can be distinguished based on the types of
receptor molecules present on the cancer cells. The classification of the tumor greatly affects the treatment and prognosis of the disease. Childhood cancers in a particular organ often are associated with different mutations than adult-onset cases of cancer in the same tissue.
Some mutations are linked to a number of different cancer types occurring in different parts of the body. Examples include mutations to telomerase, p53, or the BAF complex. Other mutations, however, are associated with very specific cancers, such as the
BRCA mutation that increase the risk of breast and ovarian cancer. Interestingly, the BRCA1 and BRCA2 genes (mutated in individuals with BRCA mutations) are tumor suppressor genes that encode proteins involved in DNA repair. These proteins and their associated repair processes occur in all cells and are important throughout the body, and we don't really understand why these mutations specifically lead to breast and ovarian cancer.